EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country

June Young Chun iD, Ah-Ra Kim iD, Hwichang Jeong, You-Jin Kim, Hae Ji Kang, Hye-Sook Jeong iD, Gi-Eun Rhie iD, Youngmee Jee, Yongdai Kim, Junewoo Lee

International Journal of Epidemiology · 17.04.2026 · 55 (3)

DOI: 10.1093/ije/dyag076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Epidemiology, online erschienen am 27.05.2026. Verfasst von June Young Chun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Cancer Center, Goyang, South Korea. Hauptthemen laut MEDLINE: Measles-Mumps-Rubella Vaccine, Measles, Rubella, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Disease Control and Prevention Agency (KDCA), National Research Foundation of Korea, Korea Health Industry Development Institute (KHIDI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The measles, mumps, and rubella (MMR) vaccine is generally considered to provide lifelong immunity against measles and rubella. However, occasional measles outbreaks in countries with high vaccine coverage have raised concerns about waning immunity. In this study, we aimed to estimate the duration of vaccine-induced immunity following MMR2 vaccination in settings where measles and rubella have been eliminated.

Methods

Using 2019 national serosurvey data, this study estimated antibody waning (decay) rates for each antigen after MMR2 vaccination, with age as a proxy for time since vaccination. In South Korea, MMR2 coverage has exceeded 95% from the 1995 birth cohort, and no significant measles or rubella outbreaks have occurred since 2001, allowing for homogeneous cohorts. Additionally, the time required for the geometric mean titers of each antibody to reach the seronegative cutoff levels was calculated.

Results

The average antibody decay rates for MMR were 8.71%, 12.02%, and 5.48% per year, respectively, after MMR2 vaccination. The duration of vaccine-induced immunity was estimated to be 19 years for measles, 9.71 years for mumps, and 31.57 years for rubella when equivocal results were considered negative. If equivocal results were considered positive, the duration would be 27.32 years for measles, 15.25 years for mumps, and 39.77 years for rubella.

Conclusion

Here, we found that individuals who have not experienced natural infection exhibited age-dependent waning of vaccine-induced immunity. While vaccination remains the most effective way to prevent disease, continued vigilance is necessary even in countries with high vaccine coverage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Measles-Mumps-Rubella VaccineMeaslesRubellaAntibodies, ViralMumpsHumansRepublic of KoreaFemaleChildChild, PreschoolMaleInfantAdolescentTime FactorsAdultVaccinationYoung Adult

Stichwörter der Autor:innen

MMR vaccineantibody decaymeasles-mumps-rubella vaccinesecondary vaccine failureseroprevalencewaning immunity

Substanzen

Measles-Mumps-Rubella VaccineAntibodies, Viral

Autor:innen und Institutionen

  • Department of Internal Medicine, National Cancer Center, Goyang, South Korea.
  • Division of Clinical Research for Vaccine, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Cheongju, Korea.
  • Department of Statistics, Seoul National University, Seoul, South Korea.
  • Division of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Cheongju, Korea.
  • Division of Acute Viral Diseases, Center for Emerging Virus Research, National Institute of Infectious Diseases, National Institute of Health, Cheongju, Korea.
  • Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Cheongju, Korea.

ORCID-Profile: June Young Chun, Ah-Ra Kim, Hye-Sook Jeong, Gi-Eun Rhie

Förderung

  • Korea Disease Control and Prevention Agency (KDCA)
  • National Research Foundation of Korea
  • Korea Health Industry Development Institute (KHIDI)
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Chun, J. Y., Kim, A. R., Jeong, H., Kim, Y. J., Kang, H. J., Jeong, H. S., Rhie, G. E., Jee, Y., Kim, Y., & Lee, J. (2026). Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country. International Journal of Epidemiology, 55(3). https://doi.org/10.1093/ije/dyag076

Vancouver

Chun JY, Kim AR, Jeong H, Kim YJ, Kang HJ, Jeong HS, et al. Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country. International Journal of Epidemiology. 2026;55(3). doi:10.1093/ije/dyag076

BibTeX
@article{Chun2026,
  author = {Chun, June Young and Kim, Ah-Ra and Jeong, Hwichang and Kim, You-Jin and Kang, Hae Ji and Jeong, Hye-Sook and Rhie, Gi-Eun and Jee, Youngmee and Kim, Yongdai and Lee, Junewoo},
  title = {Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country},
  journal = {International Journal of Epidemiology},
  year = {2026},
  volume = {55},
  number = {3},
  doi = {10.1093/ije/dyag076}
}
Kostenlos starten →